Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;9(8):858-863.
doi: 10.1530/EC-20-0316.

Prealbumin to fibrinogen ratio is closely associated with diabetic peripheral neuropathy

Affiliations

Prealbumin to fibrinogen ratio is closely associated with diabetic peripheral neuropathy

Shufei Zang et al. Endocr Connect. 2020 Aug.

Abstract

The aim of our study was to explore the diagnostic value of prealbumin to fibrinogen ratio (PFR) for predicting prognosis with the optimal cut-off value in diabetic peripheral neuropathy (DPN) patients. A total of 568 type 2 diabetes mellitus (T2DM) patients were enrolled in this study. The values including Toronto clinical neuropathy score (TCNS), nerve conduction velocity (NCV), vibration perception threshold (VPT), blood cells count, biochemical parameters, fibrinogen and PFR were recorded. The patients were divided into tertiles based on admission PFR value. First, clinical parameters were compared among the groups. Secondly, a logistic regression and ROC analysis were performed as the statistical model. The percentage of DPN, TCNS and VPT were significantly higher in the lowest PFR tertile than in the middle PFR tertile and the highest PFR tertile (P < 0.01-0.001). NCV was significantly lower in lowest PFR tertile than in the middle PFR tertile and the highest PFR tertile (P < 0.01-0.001). The Spearman correlation analysis showed that PFR was negatively correlated with TCNS and VPT (P < 0.001), while PFR was positively correlated with median motor NCV (P < 0.001), peroneal motor NCV (P < 0.001), median sensory NCV (P < 0.001), and peroneal sensory NCV (P < 0.001). After adjusting these potentially related factors, PFR was independently related to DPN (P = 0.007). The area under ROC curve was 0.627. This study finds the first evidence to suggest PFR may be the key component associated with DPN in T2DM, while PFR might underlie the pathophysiologic features of DPN.

Keywords: diabetes mellitus; diabetic peripheral neuropathy; nerve conduction velocity; prealbumin to fibrinogen ratio; type 2; vibrating perception threshold.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentage of DPN, TCNS, VPT and NCV in the different PFR tertile groups. Percentages of DPN, VPT and NCV in the different PFR tertile groups. (A) Percentages of DPN in the different PFR tertile groups were analyzed by χ2 test. (B) TCNS, (C) VPT, (D) NCV of MMN, (E) NCV of PMN, (F) NCV of MSN, (G) NCV of PSN in the different PFR tertile groups were, respectively, analyzed by one-way ANOVA test. DPN, diabetic peripheral neuropathy; TCNS, Toronto clinical neuropathy score; VPT, vibration perception threshold; NCV, nerve conduction velocity; MMN, median motor nerve; PMN, peroneal motor nerve; MSN, median sensory nerve; PSN, peroneal sensory nerve. **P < 0.01, ***P < 0.001.
Figure 2
Figure 2
ROC curve of PFR for diagnosing DPN. AUC = 0.627 (P < 0.001). PFR, prealbumin to fibrinogen ratio; DPN, diabetic peripheral neuropathy; AUC, area under ROC curve.

Similar articles

Cited by

References

    1. Spiller S, Frolov A, Hoffmann R. Quantification of specific glycation sites in humanserum albumin as prospective type 2 diabetes mellitus biomarkers. Protein and Peptide Letters 2017. 24 887–896. (10.2174/0929866524666170202124120) - DOI - PubMed
    1. Kubisz P, Stančiaková L, Staško J, Galajda P, Mokáň M. Endothelial and platelet markers in diabetes mellitus type 2. World Journal of Diabetes 2015. 6 423–431. (10.4239/wjd.v6.i3.423) - DOI - PMC - PubMed
    1. Razak MKA, Akif AM, Nakeeb N, Rasheed JI. The relationship between mean platelet volume and albuminuria in patients with type 2 diabetes mellitus. Diabetology and Metabolic Syndrome 2019. 13 2633–2639. (10.1016/j.dsx.2019.07.021) - DOI - PubMed
    1. Athyros VG, Bouloukos VI, Pehlivanidis AN, Papageorgiou AA, Dionysopoulou SG, Symeonidis AN, Petridis DI, Kapousouzi MI, Satsoglou EA, Mikhailidis DP, et al. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes, Obesity and Metabolism 2005. 7 397–405. (10.1111/j.1463-1326.2004.00409.x) - DOI - PubMed
    1. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 2017. 40 136–154. (10.2337/dc16-2042) - DOI - PMC - PubMed